22
total announcements
STAR.NS · 15 min delayed
Key Stats · Yahoo Finance · as of 20 Oct 2026
Market Cap
₹9,487 Cr
P/E (TTM)
15.5
P/E (Forward)
10.8
EPS (TTM)
₹66.55
52W Low
₹768.65
52W High
₹1,260.90
Dividend Yield
0.48%
Beta
0.37
Price / Book
3.1
Debt / Equity
55.8
Revenue (TTM)
₹5,004 Cr
Gross Margin
56.19%
Operating Margin
13.70%
Strides Pharma Science Limited
Strides Pharma Science Limited has partnered with Ascent Capital to unlock value in Pivot Path, a wholly owned subsidiary, through a strategic investment. The transaction values Pivot Path at ₹2,300m post-money, enables Strides to realise ₹1,000m while retaining a 20% stake, and includes a primary capital infusion of ₹500 million to accelerate growth.
Strides Pharma Science Limited
Strides Pharma Science Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window for dealing in shares of the Company shall remain closed from July 1, 2026, until 48 hours after declaration of the financial results of the Company for the quarter ended June 30, 2026.